Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests. The ASCP GYN PT & Assessment Committee

Size: px
Start display at page:

Download "Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests. The ASCP GYN PT & Assessment Committee"

Transcription

1 Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests The ASCP GYN PT & Assessment Committee

2 The ASCP GYN PT & Assessment Committee Robert A. Goulart, MD, Chair Jamie L. Covell, BS, CT(ASCP), Vice-chair Thomas A. Bonfiglio, MD Mark H. Stoler, MD William J. Frable, MD Carol M. Filomena, MD Syed Ali, MD Judith L. Burns, CT(ASCP) Mark Dieterich, MD Ronald D. Luff, MD, MPH Donna K. Russell, MS, CT(ASCP), HT, CMIAC Alia Salhadar, MD Maria A. Friedlander, MPA, CT(ASCP) Raja M. Gidwani, MD (Fellow Member) Enid Boeding, MD (Resident Member) Rhonda L. Metzler, SCT(ASCP), Senior Manager

3 Conflicts of Interest The Authors Have No Conflicts of Interest to Disclose.

4 Introduction Before Pap tests are entered into the American Society for Clinical Pathology (ASCP) GYN Proficiency Test (PT) program: 100% target diagnosis agreement amongst 5 committee (3 MD, 2 CT) referee reviewers Minimum performance of 90% target diagnosis agreement after 40 individual reads (validation) Biopsy confirmation (SIL and cancer cases)

5 Introduction Despite this vigorous process, a small subset of validated slides does not perform as well in actual testing.

6 Introduction When the target diagnosis agreement for any slide level falls below 90%: Immediately removed from the pool of active test slides Similarly, a small subset of slides is removed late in the validation process (between reads) What can we learn from the morphologic features of these cases?

7 Introduction Comparison of the morphologic features of "high" vs. "low" performing slides could provide information concerning subtle differences that result in less reproducible interpretations: Target diagnostic category of HSIL Both clinically significant and relatively common Inter-cytopathologist HSIL diagnostic agreement relatively poor (Diagn Cytopathol 16(1):87, 1997)

8 Conventional Pap Studies Features associated with Conventional Pap smear discrepancies in biopsy-proven CIN II/III cases in PT (Arch Pathol Lab Med 129(6):733, 2005): Fewer dysplastic cells (less than 50) Lack of large dysplastic cells Lack of keratinization Hypochromasia (not correlated with performance) Non-PT Conventional Pap studies: Processing artifacts (air-drying) Excessive blood/obscuring inflammation Sampling/rare abnormal cells

9 Liquid-Based Pap Studies Features associated with ThinPrep Pap test discrepancies in biopsy-proven CIN II/III cases in PT (Arch Pathol Lab Med 128(7):746, 2004): Fewer dysplastic cells (less than 250) Non-PT ThinPrep Pap tests (Hong Kong Med J 14(4):292, 2008): Fewer abnormal cells Fewer cells with koilocytic change Less pronounced hyperchromasia

10 Materials and Methods Two HSIL ThinPrep Pap test groups Each 30 cases (slides) High performers (HP): 90% target diagnosis agreement throughout the validation process and during active testing Low performers (LP): failed validation or were soon removed from the active test pool

11 Materials and Methods Two HSIL ThinPrep Pap test groups Each slide was re-evaluated by five committee reviewers in a blinded fashion Slides were also reviewed for overall technical quality Staining (fading)

12 Materials and Methods Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells

13 Materials and Methods Review characteristics: Reviewers instructed to note which slides they perceived might perform poorly A consensus interpretation (majority) was assigned for each category Statistical evaluation (Fisher s exact test)

14 Materials and Methods Predominant HSIL Cell Pattern

15 Materials and Methods Nucleoli Present

16 Results 59/60 slides were considered technically satisfactory Single slide within the LP group deemed technically unsatisfactory due to stain fading

17 Results Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells

18 Results Review characteristics: Predominant HSIL cell pattern (groups vs. single cells) Cell groups (< or > 10) Single HSIL cells (< or > 20) Relative number of LSIL cells Nuclear membrane irregularity Hyperchromasia Nuclear chromatin granularity (coarse vs. fine) Nucleoli (present/absent in majority of HSIL cells) N/C ratio Atrophy Atypical keratinized squamous cells Inflammation Organisms (Trichomonas and Candida) Endometrial cells

19 Results Statistically significant difference in criteria Number of cell groups (>/= 10) Number of single cells (>/= 20) Presence of nucleoli All associated with the Good Performer subset of cases Prediction of slide performance

20 Conclusions An increased quantity of HSIL cells, either in cell groups or as single cells, correlated with completion of the validation process and high field PT performance (reproducibility of HSIL target diagnosis). A high level of performance was also seen in the slides with nucleoli present in the majority of HSIL cells, albeit an infrequent finding.

21 Conclusions Although only one-half of the 30 low performing cases could be predicted by the reviewers, designation as such was highly accurate.

22 Conclusions Clinical Correlates In routine Pap test sign-out, attention to cases with rare potential HSIL cells (both in single cells and cell groups), particularly if nucleoli are present, should increase sensitivity for detection of CIN II/III. Further supporting evidence of ASC-H Stresses importance of locator skills

23 Thank you The ASCP GYN PT & Assessment Committee

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions

More information

Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000

Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000 Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000 Thomas A. Bonfiglio, M.D. Professor Emeritus, Pathology and Laboratory Medicine University of Rochester Disclosures In the past 12 months,

More information

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)

SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) ASC refers to cytologic changes suggestive of SIL, which are qualitativley or quantitatively

More information

Cytology Report Format

Cytology Report Format Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College

More information

NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA

NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure Karen Cormier, CT(ASCP), 1 Michael

More information

Morphology I Slide: 1

Morphology I Slide: 1 Morphology I Slide: 1 Morphology I Slide: 2 ThinPrep Morphology Normal Cytology Morphology I Slide: 3 CT & Pathologist Training Training program begins with ThinPrep morphology presentation Microscopic

More information

Prepared By Jocelyn Palao and Layla Faqih

Prepared By Jocelyn Palao and Layla Faqih Prepared By Jocelyn Palao and Layla Faqih The structure of the suspected atypical cell should always be compared to the structure of other similar, benign, cells which are present in the smears. The diagnosis

More information

The diagnostic category of atypical squamous cells of undetermined

The diagnostic category of atypical squamous cells of undetermined 100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.

More information

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.

More information

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases

More information

CINtec p16 INK4a Staining Atlas

CINtec p16 INK4a Staining Atlas CINtec p16 INK4a Staining Atlas Rating Rating Positive The rating positive will be assigned if the p16 INK4a -stained slide shows a continuous staining of cells of the basal and parabasal cell layers of

More information

Clinical Practice Guidelines June 2013

Clinical Practice Guidelines June 2013 Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early

More information

LGM International, Inc.

LGM International, Inc. Liqui-PREP TM Cytology Atlas Preface The following pictures are examples with descriptions of cytology slides processed with the Liqui-PREP TM System.. The descriptions are reviewed by Pathologists. It

More information

Histopathology: Cervical HPV and neoplasia

Histopathology: Cervical HPV and neoplasia Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about

More information

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital

GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital GYN (Glandulars) Still Difficult After All These Years! Dina R Mody, MD Director of Cytology Laboratories and fellowship Program Methodist Hospital and Bioreference Labs (Houston) Department of Pathology

More information

The ABCs of TBS. A Novice's Guide to the Bethesda System

The ABCs of TBS. A Novice's Guide to the Bethesda System CE U P D A T E W O M E N ' S HEALTH III Julia Woodruff Wildes, MD The ABCs of TBS A Novice's Guide to the Bethesda System This is the third and final article in a three-part series on women's health. The

More information

Case 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow

Case 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow Case 3 - GYN History: 66 year old, routine Pap test Dr. Stelow Case 3 66 year year old woman Routine Pap Test Cytologic Features 3 dimensional clusters of cells with small to moderate amount of

More information

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation

Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical

More information

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013 THE ROLE OF oncofish cervical IN THE ASSESSMENT OF CERVICAL DYSPLASIA The phone lines will open, 15 minutes prior to the start of the webinar. Toll Free: 1-800-867-0864. Entry Code: 83956484. You may download

More information

EU guidelines for reporting gynaecological cytology

EU guidelines for reporting gynaecological cytology EU guidelines for reporting gynaecological cytology Amanda Herbert Guy s & St Thomas Foundation NHS Trust 5th EFCS Annual Tutorial, Trondheim, Norway 28 th May 1 st June 2012 EU guidelines aim to harmonize

More information

Chapter 10: Pap Test Results

Chapter 10: Pap Test Results Chapter 10: Pap Test Results On completion of this section, the learner will be able to: 1. Identify how Pap test results are interpreted and the reasons for normal and abnormal results. 2. Describe the

More information

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches. Fadi W. Abdul-Karim MD MEd. Professor of Pathology. Vice chair for education. Robert Tomsich Pathology and Lab Med

More information

PAP. Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) YEAR END SUMMARY REPORT. Anatomic Pathology Programs

PAP. Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) YEAR END SUMMARY REPORT. Anatomic Pathology Programs 2005 PAP Interlaboratory Comparison Program in Cervicovaginal Cytopathology (PAP) Surveys and Educational Anatomic Pathology Programs YEAR END SUMMARY REPORT 2005 College of American Pathologists. The

More information

Cervical cytology screening has led to a reduction in cancer mortality

Cervical cytology screening has led to a reduction in cancer mortality CANCER CYTOPATHOLOGY 105 ThinPrep Pap Test Performance and Biopsy Follow-Up in a University Hospital A. Betts Carpenter, M.D., Ph.D. Diane D. Davey, M.D. Department of Pathology and Laboratory Medicine,

More information

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS

Table of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec

More information

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa

More information

Effectiveness of the ThinPrep Imaging System:

Effectiveness of the ThinPrep Imaging System: Effectiveness of the ThinPrep Imaging System: Clinical Experience in a Low Risk Screening Population Jacalyn L. Papillo, B.S., C.T., A.S.C.P., 1 * Timothy L. St. John, B.S., C.T., A.S.C.P., 1 and Gladwyn

More information

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals

PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Cytodiagnostic Study of Cervical Lesions Using the Bethesda System with Histopathological Tahera

More information

CAP Laboratory Improvement Programs

CAP Laboratory Improvement Programs CAP Laboratory Improvement Programs Comparison of Performance of Conventional and ThinPrep Gynecologic Preparations in the College of American Pathologists Gynecologic Cytology Program Andrew A. Renshaw,

More information

Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology

Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Agreement Between Cytotechnologists and Cytopathologists as a New Measure of Cytopathologist Performance in Gynecologic Cytology Andrew M. Quinn, MD 1 ; Abu T. Minhajuddin, PhD 2 ; Linda S. Hynan, PhD

More information

Comparative Features of Ductal Carcinoma In Situ and Infiltrating Ductal Carcinoma of the Breast on Fine-Needle Aspiration Biopsy

Comparative Features of Ductal Carcinoma In Situ and Infiltrating Ductal Carcinoma of the Breast on Fine-Needle Aspiration Biopsy Comparative Features of In Situ and of the Breast on Fine-Needle Aspiration Biopsy HELEN H. WANG, M.D., DR. P.H., BARBARA S. DUCATMAN, M.D., AND DAWN EICK, CT(ASCP) To evaluate the usefulness of fine-needle

More information

ACGME Competency / Milestone Assessment. The Pap Test. Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD

ACGME Competency / Milestone Assessment. The Pap Test. Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD 1 ACGME Competency / Milestone Assessment The Pap Test Ricardo R. Lastra, MD Zubair W. Baloch, MD, PhD Department of Pathology & Laboratory Medicine University of Pennsylvania, Perelman School of Medicine

More information

Cytyc Corporation - Case Presentation Archive - July 2002

Cytyc Corporation - Case Presentation Archive - July 2002 ThinPrep Pap Test History: 34 Year Old Female LMP: Day 20 Specimen Type: Cervical/Vaginal Case provided by Mark Tulecke, M.D. and Gabrielle Trawinski CT (ASCP), Mount Auburn Hospital, Cambridge, Massachusetts.

More information

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013 Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely

More information

HPV: cytology and molecular testing

HPV: cytology and molecular testing HPV: cytology and molecular testing Human Papillomavirus and how we test for it at Medlab Central Palmerston North for Cervical Cancer prevention and management. Developed by Reem Mustafa Cytology and

More information

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila

More information

Award Top Quizzes For Residents

Award Top Quizzes For Residents Award Top Quizzes For Residents Giovanni Negri, MD, Bolzano (Italy) Eva M. Wojcik MD, Department of Pathology, Loyola University, Chicago (USA) Esther D. Rossi MD, PhD, MIAC, Division of Anatomic Pathology

More information

Cervical Cytology Preparations

Cervical Cytology Preparations GYN Cytology Cervical Cytology Preparations CS TP SP Fadi W. Abdul-Karim, MD MSMedu Department of Anatomic Pathology Vice Chair Education Professor of Pathology Cleveland Clinic Cleveland Ohio Conventional

More information

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells 2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate

More information

CME/SAM. High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up

CME/SAM. High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up Anatomic Pathology / HPV Testing in Negative Papanicolaou Tests High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up Michael

More information

HPV Testing & Cervical Cancer Screening:

HPV Testing & Cervical Cancer Screening: HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success

More information

The Korean Journal of Cytopathology 13(1): 14-20, 2002

The Korean Journal of Cytopathology 13(1): 14-20, 2002 13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous

More information

Maturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : :

Maturation Index 3/29/2017. Disclosure of Relevant Financial Relationships. Gynecologic Cytology. Normal Maturation of Squamous Epithelium : : Gynecologic Cytology Fadi W. Abdul Karim, MD MEd Department of Anatomic Pathology Vice Chair Education RT PLMI Professor of Pathology Cleveland Clinic. Cleveland Ohio Disclosure of Relevant Financial Relationships

More information

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This

More information

SESSION J4. What's Next? Managing Abnormal PAPs in 2014

SESSION J4. What's Next? Managing Abnormal PAPs in 2014 37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines

More information

Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure

Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure The Korean Journal of Pathology 2012; 46: 359-364 ORIGINAL ARTICLE Outcome of Atypical Squamous Cells in Cervical Cytology: Follow-up Assessment by Loop Electrical Excision Procedure Joon Seon Song Ilseon

More information

Colposcopy. Attila L Major, MD, PhD

Colposcopy. Attila L Major, MD, PhD Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000

More information

The AutoPap Primary Screening System (APSS; Tripath Imaging,

The AutoPap Primary Screening System (APSS; Tripath Imaging, CANCER CYTOPATHOLOGY 129 A Feasibility Study of the Use of the AutoPap Screening System as a Primary Screening and Location-Guided Rescreening Device Massimo Confortini, M.D. 1 Lucia Bonardi, M.D. 1 Paolo

More information

Diagnostics: The Effect on Evidence Based Clinical Pathways. DNA vs Disease. Bruce K. Pa+erson MD CEO and President, IncellDx, Inc.

Diagnostics: The Effect on Evidence Based Clinical Pathways. DNA vs Disease. Bruce K. Pa+erson MD CEO and President, IncellDx, Inc. Diagnostics: The Effect on Evidence Based Clinical Pathways DNA vs Disease Bruce K. Pa+erson MD CEO and President, IncellDx, Inc. Who Who are we? We Are Cancer First platform to combine proteomic and genomic

More information

Human Papillomavirus Testing in Head and Neck Carcinomas

Human Papillomavirus Testing in Head and Neck Carcinomas Human Papillomavirus Testing in Head and Neck Carcinomas Guideline from the College of American Pathologists Early Online Release Publication: Archives of Pathology & Laboratory Medicine 12/18/2017 Overview

More information

CAP Laboratory Improvement Programs

CAP Laboratory Improvement Programs CAP Laboratory Improvement Programs Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology, 2006 Galen M. Eversole, MD; Ann T. Moriarty,

More information

Glandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia

Glandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia Glandular lesions in cervical cytology Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia 2nd PANNONIA CONGRESS OF PATHOLOGY, SIÓFOK, HUNGARY, 17-19 MAY

More information

Can LBC Completely Replace Conventional Pap Smear in Developing Countries

Can LBC Completely Replace Conventional Pap Smear in Developing Countries The Journal of Obstetrics and Gynecology of India (January February 2019) 69(1):69 76 https://doi.org/10.1007/s13224-018-1-7 ORIGINAL ARTICLE Can LBC Completely Replace Conventional Pap Smear in Developing

More information

Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears

Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears The Korean Journal of Pathology 2012; 46: 365-369 ORIGINAL ARTICLE Comparison of Diagnostic Cytomorphology of Atypical Squamous Cells in Liquid-Based Preparations and Conventional Smears Jung Dal Lee 1,2

More information

Making Sense of Cervical Cancer Screening

Making Sense of Cervical Cancer Screening Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because

More information

Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS

Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:

More information

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN. CLINICAL PRACTICE GUIDELINE Guideline Number: DHMP_DHMC_PG1015 Guideline Subject: Routine Cervical Cancer Screening Effective Date: 9/2018 Revision Date: 9/2019 Pages: 2 of 2 Quality Management Committee

More information

CINtec PLUS and the Pap smear: a co-testing alternative

CINtec PLUS and the Pap smear: a co-testing alternative CINtec PLUS and the Pap smear: a co-testing alternative Rosemary Tambouret MD p16/ki67 (CINtec PLUS) and the Pap smear Rosemary Tambouret MD CINtec PLUS dual stain: p16 and Ki67 p16 is anti-proliferative

More information

Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine Cervix

Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine Cervix The Korean Journal of Pathology 2011; 45: 612-620 http://dx.doi.org/10.4132/koreanjpathol.2011.45.6.612 Cytomorphologic Features According to HPV DNA Type in Histologically Proven Cases of the Uterine

More information

Use and Abuse of Onsite Adequacy for EUS-FNA of the Pancreas

Use and Abuse of Onsite Adequacy for EUS-FNA of the Pancreas Use and Abuse of Onsite Adequacy for EUS-FNA of the Pancreas Nirag Jhala MD Director of Cytopathology Perelman Center for Advanced Medicine Surgical Pathologist- GI Subspecialty Dept of Path and Lab Medicine

More information

I have no financial interests to disclose.

I have no financial interests to disclose. Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics I have no financial interests

More information

QUALITY ASSURANCE PROGRAM CYTOLOGY CYCLE 01/2018 (TRIAL)

QUALITY ASSURANCE PROGRAM CYTOLOGY CYCLE 01/2018 (TRIAL) [Pick the Date] FINAL REPORT QUALITY ASSURANCE PROGRAM CYTOLOGY CYCLE 01/2018 (TRIAL) NOTES FROM THE COORDINATOR 1. For this cycle 01/2018, a total of 32 pen drives had been circulated. Twenty-eight institutions

More information

Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation?

Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Anatomic Pathology / Monitoring HPV-16 Fractions in CIN Can HPV-16 Genotyping Provide a Benchmark for Cervical Biopsy Specimen Interpretation? Mary T. Galgano, MD, 1 Philip E. Castle, PhD, MPH, 2 Mark

More information

The Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015

The Bethesda System: Updates for th Cytopathology Congress Bursa, Turkey October 14, 2015 HARVARD MEDICAL SCHOOL The Bethesda System: Updates for 2015 6th Cytopathology Congress Bursa, Turkey October 14, 2015 David C. Wilbur, M.D. Dept. of Pathology Massachusetts General Hospital DISCLOSURES

More information

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use AJCP / Original Article The LAST Guidelines in Clinical Practice Implementing Recommendations for p16 Use Lani K. Clinton, MD, PhD, 1,2 Kyle Miyazaki, 1 Asia Ayabe, 1 James Davis, PhD, 2 Pamela Tauchi-Nishi,

More information

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 319-323 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.039

More information

Awatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan

Awatif Al-Nafussi, Gemma Rebello, Raja Al-Yusif, Euphemia McGoogan J Clin Pathol 2000;53:439 444 439 Papers Department of Pathology, Medical School, Teviot Place, Edinburgh EH8 9AG, UK A Al-Nafussi G Rebello R Al-Yusif E McGoogan Correspondence to: Dr Al-Nafussi email:

More information

Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology

Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology Morphologic Clues and Pitfalls for High Grade Lesions in Cervical Cytology Ritu Nayar, MD Northwestern University, Feinberg School of Medicine Chicago, IL, USA Disclosures Editor, Cervical Cytology Bethesda

More information

Cytopathology. Robert M Genta Pathologie Clinique Université de Genève

Cytopathology. Robert M Genta Pathologie Clinique Université de Genève Cytopathology Robert M Genta Pathologie Clinique Université de Genève Learning objectives At the end of this hour you will know: 1. What cytopathology is 2. How specimens are collected, processed, and

More information

3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project

3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship

More information

Cytopathology Education and Technology Consortium

Cytopathology Education and Technology Consortium American Society of Cytopathology Executive Board Meeting AGENDA May 3, 2010, 7:30 AM 4:00 PM, Central Valencia Room Intercontinental Hotel Chicago, Illinois Cytopathology Education and Technology Consortium

More information

Pushing the Boundaries of the Lab Diagnosis in Asia

Pushing the Boundaries of the Lab Diagnosis in Asia Pushing the Boundaries of the Lab Diagnosis in Asia Diana Lim MBBS, FRCPA, FRCPath (UK) Senior Consultant National University Health System and National University of Singapore Department of Pathology

More information

Gynecologic Cytopathology: Glandular lesions

Gynecologic Cytopathology: Glandular lesions Gynecologic Cytopathology: Glandular lesions Lin Wai Fung (MSc, MPH, CMIAC) 17/4/2014 Glandular lesions of the uterus Endocervix Endometrium Normal endocervical cells Sheets, strips well-preserved architecture:

More information

Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?

Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings? Anatomic Pathology / FALSE-NEGATIVE HISTOLOGIC FINDINGS Negative Colposcopic Biopsy After Positive Human Papilloma Virus (HPV) DNA Testing False-Positive HPV Results or False-Negative Histologic Findings?

More information

Toyonori Tsuzuki MD, PhD Professor and Chair Department of Surgical Pathology Aichi Medical University Hospital

Toyonori Tsuzuki MD, PhD Professor and Chair Department of Surgical Pathology Aichi Medical University Hospital 29th European Congress of Pathology (ECP 2017) Amsterdam RAI. The Paris System for Reporting Urinary Cytology: The Concept and Management Toyonori Tsuzuki MD, PhD Professor and Chair Aichi Medical University

More information

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988

January 15, 2009 (202) PROPOSALS TO IMPROVE CYTOLOGY PROFICIENCY TESTING REQUIRED BY THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988 DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs CMS FACT SHEET FOR IMMEDIATE RELEASE Contact:

More information

Management of Abnormal Cervical Cytology and Histology

Management of Abnormal Cervical Cytology and Histology Management of Abnormal Cervical Cytology and Histology Assoc. Prof. Gökhan Tulunay Etlik Zübeyde Hanım Women s Diseases Teaching & Research Hospital Gynecologic Oncology Clinic Universally accepted guideline

More information

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH

Cervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer

More information

ThinPrep 5000 Processor Instructions for Use

ThinPrep 5000 Processor Instructions for Use 5000 Processor Instructions for Use MAN-04008-001 Rev. 001 Page 1 of 27 INTENDED USE The 5000 processor is intended as a replacement for the conventional method of Pap smear preparation for use in screening

More information

Pancreatic malignant tumors are the fifth leading cause of cancerrelated

Pancreatic malignant tumors are the fifth leading cause of cancerrelated 44 CANCER CYTOPATHOLOGY Cytologic Criteria for Well Differentiated Adenocarcinoma of the Pancreas in Fine-Needle Aspiration Biopsy Specimens Fan Lin, M.D., Ph.D. 1 Gregg Staerkel, M.D. 2 1 Department of

More information

Cervical Cancer : Pap smear

Cervical Cancer : Pap smear Taking a PAP SMEAR Cervical Cancer : Pap smear George N Papanicolaou introduced cervical cytology in clinical practice in 1940 In 1945, PAP smear was endorsed by American cancer society as an effective

More information

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination Dr Stella Heley Senior Liaison Physician Victorian Cytology Service Victorian Cytology Service Dr Stella Heley Dr Siobhan Bourke

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Comparison of Cytologic Characteristics between Adenoid Cystic Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix

Comparison of Cytologic Characteristics between Adenoid Cystic Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix Journal of Pathology and Translational Medicine 2015; 49: 396-402 ORIGINAL ARTICLE Comparison of Cytologic Characteristics between Adenoid Cystic Carcinoma and Adenoid Basal Carcinoma in the Uterine Cervix

More information

Standards for Pathology Informatics in Australia (SPIA)

Standards for Pathology Informatics in Australia (SPIA) Standards for Pathology Informatics in Australia (SPIA) Reporting Terminology and Codes Cytopathology (v3.0) Superseding and incorporating the Australian Pathology Units and Terminology Standards and Guidelines

More information

EBUS-TBNA Diagnosis and Staging of Lung Cancer

EBUS-TBNA Diagnosis and Staging of Lung Cancer EBUS-TBNA Diagnosis and Staging of Lung Cancer Nirag Jhala MD, MIAC Professor of Pathology and Lab Med. Director of Anatomic Pathology and Cytopathology Lewis Katz School of Medicine@ Temple University

More information

Dr. Issraa Ali Hussein

Dr. Issraa Ali Hussein CLINICAL 09888888;rCYTOLOGY Dr. Issraa Ali Hussein objectives Define diagnostic cytology (clinical cytology). Explain the differences between histopathology and cytopathology. Recognize the methods for

More information

Gynecologic Cytology-Histology Correlation Guideline

Gynecologic Cytology-Histology Correlation Guideline Gynecologic Cytology- Correlation Guideline George G. Birdsong, MD and Joe W. Walker, Jr., MS, SCT(ASCP) CM Clinical Practice Committee Dr. Birdsong and Mr. Walker are grateful for extensive input from

More information

Becoming a colposcopist: Colposcope case studies

Becoming a colposcopist: Colposcope case studies Becoming a colposcopist: Colposcope case studies Seon-Kyung Lee, M.D. Department of Obstetrics and Gynecology College of Medicine, Kyung Hee University Value of Colposcopy Cytology is an effective screening

More information

Effect of human papillomavirus vaccination on cervical cancer screening in Alberta

Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence

More information

Granular lymphoblast in a case of acute lymphoblastic leukemia: A rare morphology

Granular lymphoblast in a case of acute lymphoblastic leukemia: A rare morphology www.edoriumjournals.com CLINICAL IMAGES PEER REVIEWED OPEN ACCESS Granular lymphoblast in a case of acute lymphoblastic leukemia: A rare morphology Shehab Fareed Mohamed, Dina Sameh Soliman, Firyal Ibrahim

More information

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre Original Article DOI: 10.21276/APALM.1878 A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre Rachana L Y, S.S. Hiremath*, Prabhu M H, S.S

More information

Eradicating Mortality from Cervical Cancer

Eradicating Mortality from Cervical Cancer Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus

More information

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health

More information

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Cervical Screening for Dysplasia and Cancer in Patients with HIV Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase

More information

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester

More information

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran. Assessment of Visual Inspection with Acetic Acid (VIA) as a Screening Test for Cervical Neoplasia in Comparison with Cytologic Screening in Imam Khomeini Hospital F. Ghaemmaghami, MD Associate Professor

More information

Interpretation guide. Abnormal cytology can t hide anymore

Interpretation guide. Abnormal cytology can t hide anymore Interpretation guide Abnormal cytology can t hide anymore Unique dual-biomarker technology makes you certain about the presence of transforming HPV infection. The science that creates certainty. Table

More information